VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
151 hedge funds and large institutions have $1.95B invested in Verona Pharma in 2024 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.6% less ownership
Funds ownership: 11.02% → 10.41% (-0.6%)
12% less call options, than puts
Call options by funds: $24.3M | Put options by funds: $27.6M
13% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 48
Holders
151
Holding in Top 10
11
Calls
$24.3M
Puts
$27.6M
Top Buyers
| 1 | +$112M | |
| 2 | +$54.6M | |
| 3 | +$32.3M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$32M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$30.9M |
Top Sellers
| 1 | -$75.5M | |
| 2 | -$41.4M | |
| 3 | -$35.5M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$23.6M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$15.2M |